Description
Selank 10mg + Semax 10mg | Neuropeptide Research Blend
This blend pairs two synthetic heptapeptides originally developed by Russian research institutes: Selank, an analog of the peptide tuftsin extended with a Pro-Gly-Pro tail, and Semax, an analog of the ACTH(4-10) fragment carrying the same stabilizing tail.
Selank has been characterized in models of GABAergic neurotransmission and enkephalin degradation, while Semax research has focused on brain-derived neurotrophic factor (BDNF) expression. Together they are frequently paired in neuropeptide signaling research.
Common research applications: neurotrophin expression studies, GABAergic and enkephalinase models, and comparative neuropeptide studies.
Blend composition (per vial): Selank 10mg + Semax 10mg – 20mg total peptide content.
Specifications
| Compound | Selank + Semax blend |
|---|---|
| Quantity | Selank 10mg + Semax 10mg (20mg total) per vial |
| Purity | 99%+ (HPLC/MS) |
| Form | Lyophilized powder |
| Storage | Store lyophilized at minus 20 C, protect from light. |
Frequently Asked Questions
What is in this blend?
Each vial contains Selank 10mg and Semax 10mg as a combined lyophilized powder, 20mg total peptide content.
What are Selank and Semax studied for?
Selank research has examined GABAergic signaling and enkephalin degradation; Semax research has examined BDNF expression. All work is laboratory research only.
Why are they blended?
The two peptides are frequently studied together, and a single vial with a fixed 1:1 ratio simplifies laboratory workflows.
For Research Use Only
This material is intended strictly for laboratory and research purposes. It is not intended for human or veterinary use, diagnosis, treatment, or consumption. By purchasing, the buyer confirms they are a qualified researcher and agrees to handle this product in compliance with all applicable regulations.
📚 Research guide: Read our Selank: A Research Overview of the Tuftsin-Derived Peptide
Research guide: Semax research overview
Reviews
There are no reviews yet.